Neutrophil-Lymphocyte Ratio as a Predictor of Venous Thromboembolism after Total Knee Replacement.

The Journal of Knee Surgery
Won-Woo SeoMin-Su Hyon

Abstract

Venous thromboembolism (VTE) is a potentially serious complication after total knee replacement (TKR), and recent guideline recommends thromboprophylaxis for VTE after TKR. The neutrophil-lymphocyte ratio (NLR) has emerged as a simple and new prognostic biomarker for several cardiovascular diseases. This study was performed to investigate the precise incidence of postoperative VTE and the role of NLR for predicting VTE in patients receiving thromboprophylaxis after TKR. We retrospectively enrolled 264 patients undergoing TKR who underwent routine screening enhanced pulmonary artery and lower extremity venography computed tomography (CT) scan within 7 postoperative days. Biochemical tests were performed within 2 weeks prior to surgery, and the NLR was defined as the absolute neutrophil count in peripheral blood divided by lymphocyte count. All patients received thromboprophylaxis with enoxaparin postoperatively. Of 264 patients, 102 (38.6%) were diagnosed with deep vein thrombosis (DVT) or pulmonary embolism on CT scan. Preoperative NLR was significantly higher in patients with postoperative VTE compared with that in patients without VTE (2.57 ± 1.59 vs. 2.11 ± 1.10, p = 0.011). Receiver operating characteristic curve analysis s...Continue Reading

References

Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·G NakosM E Lekka
Jun 11, 2005·Mayo Clinic Proceedings·Amir K JafferDaniel J Brotman
Oct 31, 2007·American Heart Journal·Patrick H GibsonGraham S Hillis
Sep 9, 2008·The American Journal of Cardiology·Umesh U TamhaneHitinder S Gurm
Jan 29, 2010·BMJ : British Medical Journal·Jennifer HillUNKNOWN National Clinical Guideline Centre for Acute and Chronic Conditions
Nov 3, 2010·Critical Care : the Official Journal of the Critical Care Forum·Cornelis P C de JagerPeter C Wever
Jul 28, 2011·Heart·Matthew M OrdeJohan Duflou
Mar 15, 2012·Chest·Gordon H GuyattUNKNOWN American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel
Jul 14, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hasan KayaMehmet Serdar Soydinç
Jul 3, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Eftal Murat BakirciMahmut Acikel
May 31, 2014·Journal of the National Cancer Institute·Arnoud J TempletonEitan Amir
Jan 27, 2016·Critical Reviews in Oncology/hematology·Amene Saghazadeh, Nima Rezaei
Mar 25, 2018·Journal of the Neurological Sciences·Sungwook YuMartin Krause
Mar 25, 2018·Journal of the Neurological Sciences·Simona LattanziMauro Silvestrini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.